Verona Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Verona Pharma and other ETFs, options, and stocks.

About VRNA

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. 

CEO
David S. Zaccardelli
CEODavid S. Zaccardelli
Employees
209
Employees209
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2005
Founded2005
Employees
209
Employees209

VRNA Key Statistics

Market cap
9.15B
Market cap9.15B
Price-Earnings ratio
-103.31
Price-Earnings ratio-103.31
Dividend yield
—
Dividend yield—
Average volume
1.29M
Average volume1.29M
High today
$106.45
High today$106.45
Low today
$106.21
Low today$106.21
Open price
$106.28
Open price$106.28
Volume
918.68K
Volume918.68K
52 Week high
$106.45
52 Week high$106.45
52 Week low
$27.54
52 Week low$27.54

VRNA News

TipRanks 4d
Verona Pharma Extends Severance Benefits Amid Merck Deal

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

92%

of 12 ratings
Buy
8.3%
Hold
91.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.